88 related articles for article (PubMed ID: 18752756)
1. [Diagnosing hepatocellular carcinoma using methylation specific-PCR].
Liu YH; Wu JZ; Hu XQ
Zhonghua Gan Zang Bing Za Zhi; 2008 Aug; 16(8):628-9. PubMed ID: 18752756
[No Abstract] [Full Text] [Related]
2. Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma.
Zhang Y; Li Q; Liu N; Song T; Liu Z; Guo R; Meng L
Hepatogastroenterology; 2008; 55(88):2200-6. PubMed ID: 19260505
[TBL] [Abstract][Full Text] [Related]
3. Distinct methylation patterns of benign and malignant liver tumors revealed by quantitative methylation profiling.
Lehmann U; Berg-Ribbe I; Wingen LU; Brakensiek K; Becker T; Klempnauer J; Schlegelberger B; Kreipe H; Flemming P
Clin Cancer Res; 2005 May; 11(10):3654-60. PubMed ID: 15897561
[TBL] [Abstract][Full Text] [Related]
4. [Improvement and application of methylation-specific polymerase chain reaction].
Xiao WH; Liu WW
Ai Zheng; 2004 Nov; 23(11):1354-6. PubMed ID: 15522190
[TBL] [Abstract][Full Text] [Related]
5. Diagnosing hepatocellular carcinoma: a virtual reality.
Freeman RB
Liver Transpl; 2002 Sep; 8(9):762-4. PubMed ID: 12200774
[No Abstract] [Full Text] [Related]
6. Diagnosing hepatocellular carcinoma of early stage.
Kondo F
Acta Pathol Jpn; 1990 Nov; 40(11):860-1. PubMed ID: 1963996
[No Abstract] [Full Text] [Related]
7. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.
Yeo W; Wong N; Wong WL; Lai PB; Zhong S; Johnson PJ
Liver Int; 2005 Apr; 25(2):266-72. PubMed ID: 15780049
[TBL] [Abstract][Full Text] [Related]
8. A case of hepatocellular carcinoma occurring in a cirrhotic liver--laparoscopically confirmed transition from a cirrhotic nodule to a hepatocellular carcinoma at an interval of 10 months.
Iwamura K; Hirayama S; Inaba R; Golebiowski M
Tokai J Exp Clin Med; 1984 Mar; 9(1):69-79. PubMed ID: 6100145
[TBL] [Abstract][Full Text] [Related]
9. Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications.
Debruyne EN; Delanghe JR
Clin Chim Acta; 2008 Sep; 395(1-2):19-26. PubMed ID: 18538135
[TBL] [Abstract][Full Text] [Related]
10. Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis.
Yu J; Zhang HY; Ma ZZ; Lu W; Wang YF; Zhu JD
Cell Res; 2003 Oct; 13(5):319-33. PubMed ID: 14672555
[TBL] [Abstract][Full Text] [Related]
11. Tumor-derived epigenetic changes in the plasma and serum of liver cancer patients. Implications for cancer detection and monitoring.
Wong IH; Johnson PJ; Lai PB; Lau WY; Lo YM
Ann N Y Acad Sci; 2000 Apr; 906():102-5. PubMed ID: 10818604
[No Abstract] [Full Text] [Related]
12. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and staging of hepatocellular carcinoma prior to transplantation: expertise or failure.
Varela M; Forner A; Bruix J
Liver Transpl; 2006 Oct; 12(10):1445-7. PubMed ID: 17004255
[No Abstract] [Full Text] [Related]
14. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
[TBL] [Abstract][Full Text] [Related]
15. Radiological diagnosis and staging of hepatocellular carcinoma.
Koito K; Suga T; Murashima Y
Endoscopy; 1993 Jan; 25(1):131-7. PubMed ID: 8384101
[No Abstract] [Full Text] [Related]
16. Frequent promoter methylation of M-cadherin in hepatocellular carcinoma is associated with poor prognosis.
Yamada S; Nomoto S; Fujii T; Takeda S; Kanazumi N; Sugimoto H; Nakao A
Anticancer Res; 2007; 27(4B):2269-74. PubMed ID: 17695513
[TBL] [Abstract][Full Text] [Related]
17. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
18. The use of epigenetic biomarkers for preclinical detection of hepatocellular carcinoma: potential for noninvasive screening of high-risk populations.
Rivenbark AG; Coleman WB
Clin Cancer Res; 2007 Apr; 13(8):2309-12. PubMed ID: 17438087
[No Abstract] [Full Text] [Related]
19. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan.
Hsu LS; Lee HC; Chau GY; Yin PH; Chi CW; Lui WY
Oncol Rep; 2006 Feb; 15(2):507-11. PubMed ID: 16391877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
